Section Arrow
Quote
DARE.NASDAQ
- Dare Bioscience Inc.
Quotes are at least 15-min delayed:2025/09/01 06:49 EDT
Regular Hours
Last
 2.02
-0.005 (-0.25%)
Day High 
2.08 
Prev. Close
2.025 
1-M High
2.56 
Volume 
202.11K 
Bid
2.01
Ask
2.06
Day Low
2 
Open
2 
1-M Low
1.83 
Market Cap 
27.30M 
Currency USD 
P/E 0.1 
%Yield -- 
10-SMA 2.08 
20-SMA 2.12 
50-SMA 2.38 
52-W High 9.19 
52-W Low 1.83 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.16/-1.03
Enterprise Value
28.05M
Balance Sheet
Book Value Per Share
-0.94
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.78K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CARMCarisma Therapeutics0.215-0.013-5.70%-- 
TNFATNF Pharmaceuticals Inc.0.0483-0.0133-21.59%-- 
ADAPAdaptimmune Therapeutics plc0.0589-0.01-14.51%-- 
SRPTSarepta Therapeutics18.2-0.14-0.76%15.76PE
OTLKOutlook Therapeutics0.8512-0.2388-21.91%0.58PE
Quotes are at least 15-min delayed：2025/09/01 06:49 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatmentof bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.